Capricor Therapeutics Reports Second Quarter 2016 Financial Results and Provides Clinical Update

Go back to Capricor Therapeutics Reports Second Quarter 2016 Financial Results and Provides Clinical Update
Capricor Therapeutics, Inc. (NASDAQ: CAPR) Delayed: 29.25 +0.87 (3.07%)
Previous Close $28.38    52 Week High $5.40 
Open $29.50    52 Week Low $1.88 
Day High $30.19    P/E N/A 
Day Low $28.89    EPS $0.00 
Volume 799,429